Development of an SI-traceable N-terminal pro-B-type natriuretic peptide certified reference material using structure-based impurity-corrected isotope dilution mass spectrometry approaches

• Published in: Analytical and bioanalytical chemistry 2024-06, Vol.416 (14), p.3447-3458
• Main Authors: Xiao, Peng, Chen, Jinchao, Wu, Peize, Zhang, Weifei, Sun, Zepeng, Ma, Jian, Li, Hongmei
• Format: Article
• Language: English
• Subjects: Amino acids; Analytical Chemistry; Biochemistry; Biomarkers; Biomarkers - analysis; Biomarkers - blood; Brain natriuretic peptide; Characterization and Evaluation of Materials; Chemistry; Chemistry and Materials Science; Congestive heart failure; Dilution; Food Science; Homogeneity; Humans; Impurities; Indicator Dilution Techniques; Laboratory Medicine; Mass spectrometry; Mass Spectrometry - methods; Mass spectroscopy; Monitoring/Environmental Analysis; Natriuretic Peptide, Brain - blood; Peptide Fragments - analysis; Peptide Fragments - chemistry; Peptides; Proteins; Reference materials; Reference Standards; Research Paper; Scientific imaging
• ISSN: 1618-2642; 1618-2650; 1618-2650
• DOI: 10.1007/s00216-024-05295-9

N-Terminal pro-B-type natriuretic peptide (NT-proBNP) is a pivotal biomarker for the diagnosis and prognosis of heart failure (HF). However, no SI-traceable certified reference material (CRM) or reference measurement procedure (RMP) is available for this biomarker, and so clinical testing results obtained in different laboratories cannot be traced to a higher-order standard, leading to incomparable measurements. Protein hydrolysis and protein cleavage isotope dilution mass spectrometry (AAA-IDMS and PepA-IDMS) were used to develop a CRM. Structurally related impurities were identified by high-resolution mass spectrometry. The quantitative AAA-IDMS results were corrected according to the amino acid compositions of the impurities. Using PepA-IDMS, two peptides from the proteolyzed product were confirmed as signature peptides. To obtain traceable and accurate results, the signature peptides were quantified using impurity-corrected AAA-IDMS. The candidate NT-proBNP solution was denatured and enzymatically digested using the Glu-C endoproteinase. The released signature peptides were measured using an isotopic dilution approach. The homogeneity and stability of the candidate CRM were characterized, and their uncertainties were combined with the value assignment process. The developed CRM can be considered a unique SI-traceable NT-proBNP reference material and is expected to be used as a primary calibrator for matrix NT-proBNP CRM development. Graphical Abstract